Position
Chief Financial Officer
Company
Atossa Therapeutics
SeattleBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaDescription
Atossa Therapeutics, Inc announces the appointment of Mark Daniel, CPA, as Chief Financial Officer. Mr Daniel brings over 25 years of experience in finance, revenue forecasting, and public-company controls, crucial for Atossa's commercial transition.
Quick answer
Atossa Therapeutics Appoints Mark Daniel as Chief Financial Officer (October 14, 2025). Atossa Therapeutics is based in Seattle, Washington, United States.
- Who is the new Chief Financial Officer at Atossa Therapeutics?
- Atossa Therapeutics named Mark Daniel Chief Financial Officer, announced October 14, 2025.
- What did Atossa Therapeutics announce on October 14, 2025?
- Atossa Therapeutics, Inc announces the appointment of Mark Daniel, CPA, as Chief Financial Officer. Mr Daniel brings over 25 years of experience in finance, revenue forecasting, and public-company controls, crucial for Atossa's commercial transition.
- What does Atossa Therapeutics do?
- Atossa Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative medicines in areas of significant unmet medical need in oncology with a focus on breast cancer.
- Where is Atossa Therapeutics based?
- Atossa Therapeutics is based in Seattle, Washington, United States.
- Which similar companies made leadership changes around the same time?
- Kalaris Therapeutics (November 3, 2025), Parabilis Medicines (September 3, 2025), Fate Therapeutics (October 14, 2025) and Cartesian Therapeutics, Inc. (October 8, 2025) also announced leadership changes within 45 days of Atossa Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Pharmaceutical
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Kalaris Therapeutics Appoints Matthew Gall as Chief Financial Officer (November 3, 2025)
- Parabilis Medicines Appoints Fawzi Benzaghou as Chief Medical Officer (September 3, 2025)
- Fate Therapeutics Appoints Kamal Adawi as Chief Financial Officer (October 14, 2025)
- Cartesian Therapeutics Appoints June Seymour as Chief Accounting Officer (October 8, 2025)
- Kenox Pharmaceuticals Appoints Dr. Julianne Berry as Vice President of R&D and Manufacturing (October 21, 2025)
- Halozyme Appoints Cortney Caudill as Chief Operating Officer (October 6, 2025)
Who to call at Atossa Therapeutics, and when
A new leader at Atossa Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Atossa Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Atossa Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Atossa Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Atossa Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Atossa Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.